Interferon alpha for patients with Erdheim-Chester disease

Interferon alpha for patients with Erdheim-Chester disease - IFN-alpha for patients with Erdheim-Chester disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016315

Enrollment

Registered

2015-01-23

Start date

2014-02-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erdheim-Chester disease

Interventions

Interferon-alpha

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Please refer to the protocol.

Exclusion criteria

Exclusion criteria: Please refer to the protocol.

Design outcomes

Primary

Measure	Time frame
Safety	—

Countries

Japan

Contacts

Public ContactKazuhiro Toyama

The University of Tokyo Hospital Department of Hematology and Oncology

kinchan0519ver2@yahoo.co.jp03-3815-5411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026